Cargando…

Atypical thrombosis associated with VaxZevria® (AstraZeneca) vaccine: Data from the French Network of Regional Pharmacovigilance Centres

Detalles Bibliográficos
Autores principales:	Gras-Champel, Valérie, Liabeuf, Sophie, Baud, Mariette, Albucher, Jean-François, Benkebil, Mehdi, Boulay, Charlène, Bron, Anthony, El Kaddissi, Antoine, Gautier, Sophie, Geeraerts, Thomas, Girot, Marie, Grandvuillemin, Aurélie, Laujin, Hugo, Jonville-Béra, Annie-Pierre, Masmoudi, Kamel, Massardier, Evelyne, Micallef, Joëlle, Mounier, Céline, Montastruc, François, Pariente, Antoine, Perez, Justine, Raposo, Nicolas, Salvo, Francesco, Valnet-Rabier, Marie-Blanche, Vial, Thierry, Massy, Nathalie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS. 2021
Materias:	Covid-19
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8165560/ https://www.ncbi.nlm.nih.gov/pubmed/34083026 http://dx.doi.org/10.1016/j.therap.2021.05.007

Ejemplares similares

French organization for the pharmacovigilance of COVID-19 vaccines: A major challenge
por: Lacroix, Clémence, et al.
Publicado: (2021)

COVID-19 vaccines surveillance in France: a global response to a major national challenge
por: Benkebil, Mehdi, et al.
Publicado: (2021)

Pharmacovigilance follow-up of patients in the context of the COVID-19 pandemic
por: Grandvuillemin, Aurélie, et al.
Publicado: (2023)

Pharmacovigilance signals from active surveillance of mRNA platform vaccines (tozinameran and elasomeran)
por: Valnet-Rabier, Marie-Blanche, et al.
Publicado: (2023)

French Pharmacovigilance Public System and COVID-19 Pandemic
por: Grandvuillemin, Aurélie, et al.
Publicado: (2020)

Type I interferons as the potential mechanism linking mRNA COVID-19 vaccines to Bell's palsy
por: Soeiro, Thomas, et al.
Publicado: (2021)

Role of spontaneous reporting in investigating the relationship between mRNA COVID-19 vaccines and myocarditis: The French perspective
por: Salvo, Francesco, et al.
Publicado: (2023)

French pharmacovigilance survey of casirivimab - imdevimab monoclonal antibodies in coronavirus disease (COVID-19)
por: de Canecaude, Claire, et al.
Publicado: (2023)

Risk Factors for Bleeding in Hospitalized at Risk Patients With an INR of 5 or More Treated With Vitamin K Antagonists
por: Liabeuf, Sophie, et al.
Publicado: (2015)

Risk factors for and characteristics of community‐ and hospital‐acquired drug‐induced acute kidney injuries
por: Rey, Amayelle, et al.
Publicado: (2022)

CHMP meeting highlights September 2021: Vaxzevria-related TTS
Publicado: (2021)

COVID-19, cults, and the anti-vax movement
por: Mylan, Sophie, et al.
Publicado: (2021)

Acute Pancreatitis Occurring after Pamidronate Infusions in Two Patients with Spondyloarthritis
por: Toussirot, Éric, et al.
Publicado: (2013)

Oxford-AstraZeneca COVID-19 vaccine-induced cerebral venous thrombosis and thrombocytopaenia: A missed opportunity for a rapid return of experience
por: Geeraerts, Thomas, et al.
Publicado: (2021)

Influence of Hot and Cold Environments on the Regulation of Energy Balance Following a Single Exercise Session: A Mini-Review
por: Charlot, Keyne, et al.
Publicado: (2017)

Adaptation and validation of an adverse drug reaction preventability score for bleeding due to vitamin K antagonists
por: Liabeuf, Sophie, et al.
Publicado: (2016)

Serious Neurological Adverse Events of Ceftriaxone
por: Lacroix, Clémence, et al.
Publicado: (2021)

HealVax
por: Foerster, John, et al.
Publicado: (2018)

Drug-induced lichenoid exanthema by a vaccine against COVID-19 (Vaxzevria)
por: Ziraldo, Mathieu, et al.
Publicado: (2021)

To vax or not to vax: Predictors of anti-vax attitudes and COVID-19 vaccine hesitancy prior to widespread vaccine availability
por: Roberts, Hannah A., et al.
Publicado: (2022)

Pharmacovigilance des médicaments et des vaccins contre la COVID-19 durant la pandémie : comment le Réseau français des centres régionaux de pharmacovigilance a relevé le défi ?
por: Jonville-Bera, Annie Pierre, et al.
Publicado: (2023)

Monitoring the safety of drugs and COVID-19 vaccines by the French Pharmacovigilance Centers during the pandemic: A win-win bet with Health Authorities!
por: Jonville-Bera, Annie Pierre, et al.
Publicado: (2023)

It's time to increase physical activity promotion among pregnant women in France
por: Ruart, Shelly, et al.
Publicado: (2023)

Severe thrombocytopenia after Vaxzevria vaccination in a single patient: A case report
por: Al-Ansari, Rehab Y, et al.
Publicado: (2022)

Neuralgia amiotrófica secundaria a vacuna contra COVID-19 Vaxzevria (AstraZeneca)
por: Crespo Burillo, J.A., et al.
Publicado: (2021)

Acute kidney injury associated with febuxostat and allopurinol: a post-marketing study
por: Rey, Amayelle, et al.
Publicado: (2019)

VAX Software Overview
por: DELPHI Collaboration
Publicado: (1982)

Central VAX upgrade
Publicado: (1987)

VAX support installation
por: Luque, Maria
Publicado: (2021)

Early steroid withdrawal has a positive effect on bone in kidney transplant recipients: a propensity score study with inverse probability-of-treatment weighting
por: Batteux, Benjamin, et al.
Publicado: (2020)

Drugs associated with incident fragility fractures in kidney transplant recipients
por: Batteux, Benjamin, et al.
Publicado: (2022)

Neuromuscular Activity during Cycling Performance in Hot/Dry and Hot/Humid Conditions
por: Baillot, Michelle, et al.
Publicado: (2021)

Serum negative neuromyelitis optica spectrum disorder after vaxzevria vaccination: A case report
por: Gorgone, Gaetano, et al.
Publicado: (2021)

Can a supranational medicines agency restore trust after vaccine suspensions? The case of Vaxzevria
por: Albanese, Andrea, et al.
Publicado: (2022)

Incidence and preventability of hospital admissions for adverse drug reactions in France: A prospective observational study (IATROSTAT)
por: Laroche, Marie‐Laure, et al.
Publicado: (2022)

Prenatal Counseling throughout Pregnancy: Effects on Physical Activity Level, Perceived Barriers, and Perinatal Health Outcomes: A Quasi-Experimental Study
por: Ruart, Shelly, et al.
Publicado: (2020)

Association Between Maternal Body Mass and Physical Activity Counseling During Pregnancy
por: Ruart, Shelly, et al.
Publicado: (2021)

P02-07 Physical activity promotion project: intervention and evaluation among pregnant women
por: Ruart, Shelly, et al.
Publicado: (2022)

Fetal and Neonatal Adverse Drug Reactions Associated with Biologics Taken During Pregnancy by Women with Autoimmune Diseases: Insights from an Analysis of the World Health Organization Pharmacovigilance Database (VigiBase(®))
por: Dernoncourt, Amandine, et al.
Publicado: (2022)

Evaluation of Changes Over Time in the Drug Burden and Medication Regimen Complexity in ESRD Patients Before and After Renal Transplantation
por: Marienne, Justine, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_pt0ahvomo015epaueidr1i1dug